ARCHIVES

CMS To Recognize NCCN’s Drug Compendium.

This article is from The Cancer Letter archive.

Vol. 34 No. 22 | June 6, 2008

Download PDF Visit The Full Archive

Related Articles

Advisors Approve New Grant Programs In Breast Pre-Malignancy, Lung Inflammation

November 17, 2006

NCI Panel Urges Smaller Pilot Trials In Pancreatic Cancer

November 6, 2009

FDA Approves Rituxan For CLL

February 19, 2010

In Brief: EORTC-NCI Exchange Program Invites U.S. applicants; USC Seeks Eye Melanoma Patients

December 5, 1986

NHGRI’s ENCODE project to identify all genome parts.

October 10, 2003

NCAB Seeks Exemption From New Reimbursement Plan For Clinical Trials, Modification Of Hospice Regs

February 11, 1983